Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy? Check back later for a possible video summary. Videos are created for most articles. Introduction Cardiovascular disease (CVD) remains the leading cause of death for most racial and ethnic
Cardiology
GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis
GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis Check back later for a possible video summary. Videos are created for most articles. Abstract The treatment landscape for managing weight in non-diabetic patients has changed dramatically with the introduction
Comparative Analysis of Fish Oil and Algae-Based Omega-3 Supplements
Breaking Free: How Mounjaro Helps Smokers Quit Without Nicotine Patches
Breaking Free How Mounjaro Helps Smokers Quit Without Nicotine Patches Check back later for a possible video summary. Videos are created for most articles. Introduction Breaking Free: How Mounjaro Helps Smokers Quit Without Nicotine Patches In 2021, almost 46 million adults in the United States reported using nicotine products, and research on the
Silent Warning Signs: Why Stroke Rates Are Surging Among People Under 40
Is Clonal Hematopoiesis a New Cardiovascular Risk Factor?
Is Clonal Hematopoiesis a New Cardiovascular Risk Factor? Check back later for a possible video summary. Videos are created for most articles. Abstract This paper explores growing evidence that links clonal hematopoiesis, particularly clonal hematopoiesis of indeterminate potential (CHIP), to an increased risk of
Stroke Technology in 2025: New Treatments Giving Patients a Second Chance
New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence
New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence Please like and subscribe if you enjoyed this video :-) Introduction Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, remains one of the most common and life-threatening complications in patients with cancer.
From COVID to Cancer: Understanding Hypercoagulability in Modern Practice – How Coagulopathies Evolved During the Pandemic
The Mystery of the Low Platelet Count: When is it ITP, and When is it Not? – Diagnostic pearls and Red flags for Thrombocytopenia
